Healthcare Sales & Marketing Network News: Aduro BioTech

Searching News Database: Aduro BioTech

HSMN NewsFeed - 11 Nov 2021
Actym Therapeutics Appoints Chan Whiting as Chief Development Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Jul 2021
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jul 2016
Janssen Announces Clinical Collaboration with Bristol-Myers Squibb to Evaluate Immuno-oncology Combination in Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Jan 2015
Aduro Biotech Closes $51.4 Million Series D Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 29 May 2014
Aduro Announces License Agreement with Johnson & Johnson Innovation for Novel Immunotherapies for Prostate Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 31 Jan 2013
Aduro Announces $6.5 Million Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 11 Oct 2011
Aduro BioTech Announces First Patient Treated in Phase 2 Pancreatic Cancer Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Apr 2011
Aduro BioTech Completes $19.25 Million Series B Financing
Biopharmaceuticals Venture Capital

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.